Prevalence and comorbidity of diabetes mellitus among non-institutionalized older adults in Germany - Results of the national telephone health interview survey German Health Update (GEDA) 2009

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Du, Yong ^a   Heidemann, Christin ^a   Göwald, Antje ^a   Schmich, Patrick ^a   Scheidt Nave, Christa ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Comorbidity; Diabetes; Germany; Prevalence

Indexed keywords

AGED; ARTICLE; COMORBIDITY; DIABETES MELLITUS; FEMALE; GERMANY; HEALTH SURVEY; HUMAN; INSTITUTIONALIZATION; MALE; MIDDLE AGED; PREVALENCE; QUALITATIVE RESEARCH; TELEPHONE;

AGED; COMORBIDITY; DIABETES MELLITUS; FEMALE; GERMANY; HEALTH SURVEYS; HUMANS; INSTITUTIONALIZATION; MALE; MIDDLE AGED; PREVALENCE; QUALITATIVE RESEARCH; TELEPHONE;

MLCS; MLOWN;

EID: 84874090346     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-166     Document Type: Article

References (65)

1. Global and societal implications of the diabetes epidemic. Zimmet P, Alberti KG, Shaw J, Nature 2001 414 6865 782 787 10.1038/414782a 11742409 (Pubitemid 34000780)
2. The effects of complications and comorbidities on the quality of preventive diabetes care: a literature review. Conwell LJ, Boult C, Popul Health Manag 2008 11 4 217 228 10.1089/pop.2007.0017 18942927
3. Beyond comorbidity counts: how do comorbidity type and severity influence diabetes patients' treatment priorities and self-management? Kerr EA, Heisler M, Krein SL, Kabeto M, Langa KM, Weir D, Piette JD, J Gen Int Med 2007 22 12 1635 1640 10.1007/s11606-007-0313-2 (Pubitemid 350160334)
4. Prevention of diabetes mellitus. Report of a WHO Study Group. World Health Organization, World Health Organ Tech Rep Ser 1994 844 1 100 7941615
5. International Diabetes Federation, IDF Diabetes Atlas Brussels, Belgium: International Diabetes Federation 5 2011
6. Medical care of type 2 diabetes in German Disease Management Programmes: a population-based evaluation. Stark RG, Schunk MV, Meisinger C, Rathmann W, Leidl R, Holle R, for the KSG, Diabetes Metab Res Rev 2011 27 4 383 391 10.1002/dmrr.1186 21308948
7. The pre-therapeutic classification of co-morbidity in chronic disease. Feinstein AR, J Chron Dis 1970 23 7 455 468 10.1016/0021-9681(70)90054-8
8. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. Kaplan MH, Feinstein AR, J Chron Dis 1974 27 7-8 387 404 4436428
9. Defining comorbidity: implications for understanding health and health services. Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M, Ann Fam Med 2009 7 4 357 363 10.1370/afm.983 19597174
10. Quality of care for older patients with diabetes mellitus with comorbidity. Boyd CM, Leff B, J Am Geriatr Soc 2006 54 3 553 554 16551337 (Pubitemid 43327183)
11. Prevalence of known diabetes in German adults aged 25-69years: results from national health surveys over 15years. Heidemann C, Kroll L, Icks A, Lampert T, Scheidt-Nave C, Diabet Med 2009 26 6 655 658 10.1111/j.1464-5491.2009.02739. x 19538243
12. Regional differences in the prevalence of known type 2 diabetes mellitus in 45-74years old individuals: Results from six population-based studies in Germany (DIAB-CORE Consortium). Schipf S, Werner A, Tamayo T, Holle R, Schunk M, Maier W, Meisinger C, Thorand B, Berger K, Mueller G, Diabet Med 2012 29 7 88 e95 10.1111/j.1464-5491.2012.03578.x 22248078
13. The cost burden of diabetes mellitus: the evidence from Germany - the CoDiM Study. Köster I, von Ferber L, Ihle P, Schubert I, Hauner H, Diabetologia 2006 49 7 1498 1504 10.1007/s00125-006-0277-5 16752168 (Pubitemid 43848085)
14. Direct costs of diabetes mellitus in Germany-CoDiM 2000-2007. Köster I, Huppertz E, Hauner H, Schubert I, Exp Clin Endocrinol Diabetes 2011 119 6 377 385 10.1055/s-0030-1269847 21264804
15. Follow up of the CoDiM-Study: Cost of diabetes mellitus 2000-2009. Köster I, Schubert I, Huppertz E, Dtsch Med Wochenschr 2012 137 19 1013 1016 22549261
16. Diabetes prevalence based on health insurance claims: large differences between companies. Hoffmann F, Icks A, Diabet Med 2011 28 8 919 923 10.1111/j.1464-5491.2011.03305.x 21429008
17. Prävalenz, medikamentöse Behandlung und Einstellung des Diabetes mellitus in der Hausarztpraxis*. Pittrow D, Stalla G, Zeiher A, Silber S, März W, Pieper L, Klotsche J, Glaesmer H, Ruf G, Schneider H, Med Klin Intensivmed Notfallmed 2006 101 8 635 644 10.1007/s00063-006-1093-x (Pubitemid 44213103)
18. Complications, co-morbidity, and blood glucose control in type 2 diabetes mellitus patients in Germany-results from the CODE-2 study. Liebl A, Neiss A, Spannheimer A, Reitberger U, Wieseler B, Stammer H, Goertz A, Exp Clin Endocrinol Diabetes 2002 110 1 10 16 10.1055/s-2002-19988 11835119 (Pubitemid 34136276)
19. Prevalence and patterns of morbidity among adults in Germany. Results of the German telephone health interview survey German Health Update (GEDA) 2009. Fuchs J, Busch M, Lange C, Scheidt-Nave C, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2012 55 4 576 586 10.1007/s00103-012- 1464-9 22441528
20. Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims data based cross-sectional study in Germany. van den Bussche H, Koller D, Kolonko T, Hansen H, Wegscheider K, Glaeske G, von Leitner EC, Schafer I, Schon G, BMC Public Health 2011 11 101 10.1186/1471-2458-11-101 21320345
21. The influence of age, gender and socio-economic status on multimorbidity patterns in primary care. first results from the multicare cohort study. Schafer I, Hansen H, Schon G, Hofels S, Altiner A, Dahlhaus A, Gensichen J, Riedel-Heller S, Weyerer S, Blank W, BMC Health Serv Res 2012 12 1 89 10.1186/1472-6963-12-89 22471952
22. Koch-Institut R, Daten und Fakten: Ergebnisse der Studie 'Gesundheit in Deutschland aktuell 2009' Berlin: Robert Koch Institut 2011
23. Idiosyncrasies in telephone sampling-The case of Germany. Gabler S, Häder S, Int J Public Opin Res 2002 14 3 339 345 10.1093/ijpor/14.3.339 (Pubitemid 37446498)
24. Final Dispositions of Case Codes and Outcome Rates for Surveys. Revised 2009. Standard Definitions, http://www.aapor.org/AM/Template.cfm?Section= Standard-Definitions%20&Template=/CM/ContentDisplay.cfm&ContentID=1819.
25. Creating a coherent set of indicators to monitor health across Europe. Robine J-M, Jagger C, Group TE-R, Euro J Public Health 2003 13 suppl 1 6 14 (Pubitemid 37158438)
26. The impact of comorbid chronic conditions on diabetes care. Piette JD, Kerr EA, Diabetes Care 2006 29 3 725 731 10.2337/diacare.29.03.06.dc05-2078 16505540 (Pubitemid 44115387)
27. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. WHO Expert Consultation, Lancet 2004 363 9403 157 163 14726171
28. Class and education in industrial nations. Müller W, Lüttinger P, König W, Karle W, Int J Sociol 1989 19 36
29. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Lancet 2011 378 9785 31 40 10.1016/S0140-6736(11)60679-X 21705069
30. Diabetes prevalence and diagnosis in US states: analysis of health surveys. Danaei G, Friedman AB, Oza S, Murray CJ, Ezzati M, Popul Health Metr 2009 7 16 10.1186/1478-7954-7-16 19781056
31. Socioeconomic position and health among persons with diabetes mellitus: a conceptual framework and review of the literature. Brown AF, Ettner SL, Piette J, Weinberger M, Gregg E, Shapiro MF, Karter AJ, Safford M, Waitzfelder B, Prata PA, Epidemiol Rev 2004 26 1 63 77 10.1093/epirev/mxh002 15234948 (Pubitemid 38864738)
32. Diabetes 'epidemic' in Germany? A critical look at health insurance data sources. Hoffmann F, Icks A, Exp Clin Endocrinol Diabetes 2012 120 7 410 415 22441721
33. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS, Bainbridge KE, Fradkin JE, Diabetes Care 2010 33 3 562 10.2337/dc09-1524 20067953
34. A first national prevalence estimate of diagnosed and undiagnosed diabetes in France in 18- to 74-year-old individuals: the French Nutrition and Health Survey 2006/2007. Bonaldi C, Vernay M, Roudier C, Salanave B, Oleko A, Malon A, Castetbon K, Fagot-Campagna A, Diabet Med 2011 28 5 583 589 10.1111/j.1464-5491.2011.03250.x 21294766
35. Increasing socio-economic inequality in type 2 diabetes prevalence-repeated cross-sectional surveys in England 1994-2006. Imkampe AK, Gulliford MC, Eur J Public Health 2011 21 4 484 490 10.1093/eurpub/ckq106 20685812
36. Microvascular and macrovascular complications of diabetes. Fowler MJ, Clin Diab 2008 26 2 77 82 10.2337/diaclin.26.2.77 (Pubitemid 351556223)
37. Diabetes mellitus and visual impairment: National health and nutrition examination survey, 1999-2004. Zhang X, Gregg EW, Cheng YJ, Thompson TJ, Geiss LS, Duenas MR, Saaddine JB, Arch Ophthalmol 2008 126 10 1421 1427 10.1001/archopht.126.10.1421 18852421
38. Prevalence of diabetic retinopathy in the United States, 2005-2008. Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, Gregg EW, Albright AL, Klein BEK, Klein R, JAMA 2010 304 6 649 656 10.1001/jama.2010.1111 20699456
39. Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Augood CAVJ, Vingerling JR, de Jong PT, Chakravarthy U, Seland J, Soubrane G, Tomazzoli L, Topouzis F, Bentham G, Rahu M, Vioque J, Young IS, Fletcher AE, Arch Ophthalmol 2006 124 4 529 535 10.1001/archopht.124. 4.529 16606879
40. Retinopathy in diabetes. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, Klein R, Diabetes Care 2004 27 suppl 1 84 s87 14693935
41. Diabetes in chronic liver disease: from old concepts to new evidence. Picardi A, D'Avola D, Gentilucci UV, Galati G, Fiori E, Spataro S, Afeltra A, Diabetes Metab Res Rev 2006 22 4 274 283 10.1002/dmrr.636 16506276 (Pubitemid 44070503)
42. Association between diagnosed diabetes and self-reported cancer among U.S. adults: findings from the 2009 Behavioral Risk Factor Surveillance System. Li C, Balluz LS, Ford ES, Okoro CA, Tsai J, Zhao G, Diabetes Care 2011 34 6 1365 1368 10.2337/dc11-0020 21505205
43. Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype. Berenbaum F, Ann Rheum Dis 2011 70 8 1354 1356 10.1136/ard.2010.146399 21474484
44. Non-insulin dependent diabetes mellitus (NIDDM) and patterns of osteoarthritis. The Ulm osteoarthritis study. Sturmer T, Brenner H, Brenner RE, Gunther KP, Scand J Rheumatol 2001 30 3 169 171 10.1080/030097401300162969 11469529 (Pubitemid 32476923)
45. Diabetes and cancer: a consensus report. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D, Diabetes Care 2010 33 7 1674 1685 10.2337/dc10-0666 20587728
46. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Ehrlich SF, Quesenberry CP Jr, Van Den Eeden SK, Shan J, Ferrara A, Diabetes Care 2010 33 1 55 60 10.2337/dc09-0880 19808918
47. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Rana JS, Mittleman MA, Sheikh J, Hu FB, Manson JE, Colditz GA, Speizer FE, Barr RG, Camargo CA Jr, Diabetes Care 2004 27 10 2478 2484 10.2337/diacare.27.10.2478 15451919 (Pubitemid 39281404)
48. The association between Helicobacter pylori infection and insulin resistance: a systematic review. Polyzos SA, Kountouras J, Zavos C, Deretzi G, Helicobacter 2011 16 2 79 88 10.1111/j.1523-5378.2011.00822.x 21435084
49. Relationship of type 2 diabetes to the prevalence, incidence and progression of age-related hearing loss. Mitchell P, Gopinath B, McMahon CM, Rochtchina E, Wang JJ, Boyages SC, Leeder SR, Diabet Med 2009 26 5 483 488 10.1111/j.1464-5491.2009.02710.x 19646187
50. Depression and type 2 diabetes: inflammatory mechanisms of a psychoneuroendocrine co-morbidity. Stuart MJ, Baune BT, Neurosci Biobehav Rev 2012 36 1 658 676 10.1016/j.neubiorev.2011.10.001 22020230
51. Costs of long-term complications in type 2 diabetes patients in Germany. Results of the CODE-2 Study. Liebl A, Spannheimer A, Reitberger U, Gortz A, Med Klin 2002 97 12 713 719 Munich 10.1007/s00063-002-1215-z (Pubitemid 36019788)
52. The prevalence of multiple diabetes-related complications. Morgan CL, Currie CJ, Stott NC, Smithers M, Butler CC, Peters JR, Diabet Med 2000 17 2 146 151 10.1046/j.1464-5491.2000.00222.x 10746486 (Pubitemid 30159051)
53. The changing prevalence of diagnosed diabetes and its associated vascular complications in a large region of the UK. Morgan CL, Peters JR, Currie CJ, Diabet Med 2010 27 6 673 678 10.1111/j.1464-5491.2010.02912.x 20546286
54. Validation of the Cumulative Illness Rating Scale in a geriatric residential population. Parmelee PA, Thuras PD, Katz IR, Lawton MP, J Am Geriatr Soc 1995 43 2 130 137 7836636
55. Cumulative illness rating scale. Linn BS, Linn MW, Gurel L, J Am Geriatr Soc 1968 16 5 622 626 5646906
56. The curiously strong relationship between cardiovascular disease and depression in the elderly. Nemeroff CB, Am J Geriatr Psychiatry 2008 16 11 857 860 10.1097/JGP.0b013e318189806a 18978246
57. Recent advances in COPD: pathophysiology, respiratory physiology and clinical aspects, including comorbidities. Bourdin A, Burgel PR, Chanez P, Garcia G, Perez T, Roche N, Eur Respir Rev 2009 18 114 198 212 10.1183/09059180.00005509 20956145
58. Prevalence of cardiovascular disease risk factors among US adults with self-reported osteoarthritis: data from the Third National Health and Nutrition Examination Survey. Singh G, Miller JD, Lee FH, Pettitt D, Russell MW, Am J Manag Care 2002 8 15 Suppl 383 S391 12416788
59. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Naranjo A, Sokka T, Descalzo M, Calvo-Alén J, Horslev-Petersen K, Luukkainen R, Combe B, Burmester G, Devlin J, Ferraccioli G, Arthritis Res Ther 2008 10 2 1 10 10.1186/ar2462
60. Aging with multimorbidity: A systematic review of the literature. Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, Meinow B, Fratiglioni L, Ageing Res Rev 2011 10 4 430 439 10.1016/j.arr.2011.03.003 21402176
61. The effect of diabetes on sensorineural hearing loss. Kakarlapudi V, Sawyer R, Staecker H, Otol Neurotol 2003 24 3 382 386 10.1097/00129492- 200305000-00006 12806288 (Pubitemid 36618158)
62. A comparison of prevalence estimates for selected health indicators and chronic diseases or conditions from the Behavioral Risk Factor Surveillance System, the National Health Interview Survey, and the National Health and Nutrition Examination Survey, 2007-2008. Li C, Balluz LS, Ford ES, Okoro CA, Zhao G, Pierannunzi C, Prev Med 2012 54 6 381 387 10.1016/j.ypmed.2012.04.003 22521996
63. Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study). Turner EL, Lane JA, Donovan JL, Davis MJ, Metcalfe C, Neal DE, Hamdy FC, Martin RM, Int J Cancer 2011 128 2 440 446 10.1002/ijc.25360 20473853
64. Health care utilization and costs in Saskatchewan's registered Indian population with diabetes. Pohar S, Johnson J, BMC Health Serv Res 2007 7 1 126 10.1186/1472-6963-7-126 17697326 (Pubitemid 47407723)
65. Comparison of routine care self-reported and biometrical data on hypertension and diabetes: results of the Utrecht Health Project. Molenaar EA, Ameijden EJCV, Grobbee DE, Numans ME, Euro J Public Health 2007 17 2 199 205 10.1093/eurpub/ckl113 (Pubitemid 46536736)